Averion Oncology Business Unit
Averion’s Oncology Business Unit is a cross-organizational team comprised of over 75 operational, medical, financial, and senior management staff dedicated to our clients’ oncology studies. The team is led by Gene Resnick, MD, a board-certified oncologist, with 30 years of experience in cancer drug development.
The Oncology Business Unit offers:
- Oncology Center of Excellence for Training and Best-Practices
- Translational Research & First-In-Man Clinical Services
- Evidence-based Feasibility Studies
- Oncology-Focused Patient Recruitment
- Rapid Study Start-Up Strategies
- Predictive Sciences™ Consulting
- Expert Safety Analysis
Averion brings our clients dedicated oncology clinical teams who are experts in planning, initiating, managing and reporting oncology trials in support of regulatory approvals and post-marketing studies.
We have extraordinary experience in broad clinical indications, and cutting-edge therapeutics including:
- Monoclonal Ab
- Small Molecules
- Biologics
- Vaccines
- Hormones
- Liposomes
Averion has supported cancer clinical trials for over 25 years. Our success includes strategic and regulatory consulting, clinical development planning, and full-service implementation of Phase I – IV studies, compassionateaccess programs and surveillance registries.
Talk to us about how the Averion Oncology Business Unit can help you meet your target. Email Us Now.